Schizophrenia.com
Sunovion, PsychoGenics nondopamine schizophrenia drug meets phase 2 endpoint
News
everhopeful
December 13, 2018, 6:35pm
1
6 Likes
everhopeful
December 13, 2018, 7:05pm
2
Firemonkey already posted this. Apologies.
firemonkey
December 13, 2018, 8:40pm
3
It pushed the info up the page so no worries
1 Like
Related topics
Topic
Replies
Views
Activity
Sunovion and PsychoGenics Announce Positive Results from Pivotal Phase 2 Study of Novel Investigational Agent SEP-363856 for the Treatment of Schizophrenia
News
4
433
December 13, 2018
Sunovion and PsychoGenics Initiate DIAMOND Phase 3 Clinical Studies
News
8
493
September 28, 2019
Sunovion Announces Results from Its Open-Label Extension Study of SEP-363856
News
3
371
December 13, 2019
Drug For Schizophrenia Beginning Phase II Trial
News
14
1335
December 3, 2016
FDA Grants Breakthrough Designation to Novel Schizophrenia Drug
News
18
1434
September 8, 2019